FR14C0066I1 - - Google Patents

Info

Publication number
FR14C0066I1
FR14C0066I1 FR14C0066C FR14C0066I1 FR 14C0066 I1 FR14C0066 I1 FR 14C0066I1 FR 14C0066 C FR14C0066 C FR 14C0066C FR 14C0066 I1 FR14C0066 I1 FR 14C0066I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR14C0066I1 publication Critical patent/FR14C0066I1/fr
Application granted granted Critical
Publication of FR14C0066I2 publication Critical patent/FR14C0066I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR14C0066C 2002-10-11 2014-09-11 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles Active FR14C0066I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002298259 2002-10-11
PCT/JP2003/013070 WO2004033463A1 (ja) 2002-10-11 2003-10-10 ２，３−ジヒドロ−６−ニトロイミダゾ[２，１−ｂ]オキサゾール化合物

Publications (2)

Publication Number Publication Date
FR14C0066I1 true FR14C0066I1 (enrdf_load_stackoverflow) 2014-10-17
FR14C0066I2 FR14C0066I2 (fr) 2015-05-22

Family

ID=32089299

Family Applications (1)

Application Number Title Priority Date Filing Date
FR14C0066C Active FR14C0066I2 (fr) 2002-10-11 2014-09-11 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles

Country Status (26)

Country Link
US (1) US7262212B2 (enrdf_load_stackoverflow)
EP (2) EP1555267B1 (enrdf_load_stackoverflow)
JP (1) JP4186065B2 (enrdf_load_stackoverflow)
KR (1) KR100723847B1 (enrdf_load_stackoverflow)
CN (4) CN102532162B (enrdf_load_stackoverflow)
AR (4) AR041198A1 (enrdf_load_stackoverflow)
AU (1) AU2003272979B2 (enrdf_load_stackoverflow)
BE (1) BE2014C053I2 (enrdf_load_stackoverflow)
BR (1) BRPI0314344B8 (enrdf_load_stackoverflow)
CA (1) CA2497569C (enrdf_load_stackoverflow)
CY (2) CY1113578T1 (enrdf_load_stackoverflow)
DK (1) DK1555267T3 (enrdf_load_stackoverflow)
ES (1) ES2400179T3 (enrdf_load_stackoverflow)
FR (1) FR14C0066I2 (enrdf_load_stackoverflow)
HU (1) HUS1400046I1 (enrdf_load_stackoverflow)
LU (1) LU92517I2 (enrdf_load_stackoverflow)
MX (1) MXPA05003674A (enrdf_load_stackoverflow)
MY (1) MY139244A (enrdf_load_stackoverflow)
PL (3) PL409525A1 (enrdf_load_stackoverflow)
PT (1) PT1555267E (enrdf_load_stackoverflow)
RU (1) RU2326121C3 (enrdf_load_stackoverflow)
SI (1) SI1555267T1 (enrdf_load_stackoverflow)
TW (1) TWI347946B (enrdf_load_stackoverflow)
UA (1) UA83200C2 (enrdf_load_stackoverflow)
WO (1) WO2004033463A1 (enrdf_load_stackoverflow)
ZA (1) ZA200501033B (enrdf_load_stackoverflow)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4564713B2 (ja) 2000-11-01 2010-10-20 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
KR100655670B1 (ko) * 2002-10-15 2007-02-28 오쓰까 세이야꾸 가부시키가이샤 1-치환된 4-니트로이미다졸 화합물 및 이의 제조 방법
JP4761756B2 (ja) * 2003-10-31 2011-08-31 大塚製薬株式会社 ２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物
ATE410430T1 (de) 2003-10-31 2008-10-15 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
TWI300409B (en) 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
PL1731518T3 (pl) 2004-03-31 2014-11-28 Nippon Soda Co Cykliczny związek aminowy oraz środek zwalczający szkodniki
JP4787529B2 (ja) * 2004-04-09 2011-10-05 大塚製薬株式会社 医薬組成物
JP4789966B2 (ja) * 2004-04-09 2011-10-12 大塚製薬株式会社 医薬組成物
ES2337728T3 (es) * 2005-06-20 2010-04-28 Schering Corporation Piperidinas sustituidas unidas a carbono y sus derivados utiles como antagonistas de histamina h3.
UA95251C2 (ru) * 2005-07-28 2011-07-25 Оцука Фармасьютикал Ко., Лтд. ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ПРОИЗВОДНЫЕ 2,3-ДИГИДРО-6-НИТРОИМИДАЗО[2,1-b]ОКСАЗОЛА
JP5105818B2 (ja) * 2005-10-05 2012-12-26 大塚製薬株式会社 医薬組成物
TW201233389A (en) * 2005-10-05 2012-08-16 Otsuka Pharma Co Ltd Antituberculous therapeutic drugs and kit containing the same
AR057540A1 (es) * 2005-10-06 2007-12-05 Nippon Soda Co Compuestos cruzados de ciclicamina y agentes para control de plagas
TW200800268A (en) 2005-11-04 2008-01-01 Otsuka Pharma Co Ltd Medicinal composition showing improved drug absorbability
CA2636929A1 (en) 2005-12-21 2007-07-12 Decode Genetics, Ehf Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
US20090018169A1 (en) * 2006-02-13 2009-01-15 Laboratoires Serono Sa Sulfonamide Derivatives for the Treatment of Bacterial Infections
JP2007297305A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
JP5486928B2 (ja) * 2007-02-26 2014-05-07 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックウレアおよびカルバメートインヒビター
AR070301A1 (es) * 2007-05-08 2010-03-31 Otsuka Pharma Co Ltd Compuesto epoxi y metodo para producir el mismo
TW200911796A (en) * 2007-07-26 2009-03-16 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
WO2009021965A2 (en) * 2007-08-15 2009-02-19 Glaxo Group Limited Substituted quinoline derivatives as h1 receptor antagonists
US20100222349A1 (en) * 2007-10-16 2010-09-02 Glaxo Group Limited Quinoline derivatives used to treat inflammatory and allergic diseases
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
US8592409B2 (en) 2008-01-24 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
CA2715290A1 (en) * 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2274287B1 (en) * 2008-03-18 2016-03-09 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
CN101965353B (zh) * 2008-03-26 2014-12-17 丹诺医药(苏州）有限公司 共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
AR071236A1 (es) 2008-05-01 2010-06-02 Vitae Pharmaceuticals Inc Inhibidores ciclicos de la 11beta-hidroxiesteroide deshidrogenasa 1
AR071609A1 (es) * 2008-05-01 2010-06-30 Vitae Pharmaceuticals Inc Inhibidores ciclicos de 11(beta) -hidroxiesteroide deshidrogenasa 1
WO2009134384A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
NZ590495A (en) 2008-07-25 2012-10-26 Vitae Pharmaceuticals Inc Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
PE20110368A1 (es) * 2008-08-18 2011-06-13 Univ Yale Moduladores de mif
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
WO2010143007A1 (en) * 2009-06-10 2010-12-16 Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik Method for the production of 2-halogeno-4-nitroimidazole
ES2476967T3 (es) 2008-08-21 2014-07-15 Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik Métodos para la producción de 2-halo-4-nitroimidazol e intermedios del mismo
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
US20100331320A1 (en) * 2009-04-30 2010-12-30 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
BR112012002214B1 (pt) 2009-07-31 2022-01-25 Global Alliance For Tb Drug Development Análogos de nitroimidazooxazina e nitroimidazooxazol, seus usos e composição farmacêutica
US9198913B2 (en) 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
JP5781072B2 (ja) * 2009-07-31 2015-09-16 グローバル、アライアンス、フォア、ティービー、ドラッグ、ディベロップメント ニトロイミダゾオキサジンおよび抗−結核療法におけるその使用
US20120219500A1 (en) 2009-10-26 2012-08-30 Fujifilm Ri Pharma Co., Ltd. Diagnostic agent for infectious diseases
TW201200523A (en) 2010-01-29 2012-01-01 Otsuka Pharma Co Ltd Synthetic intermediate of oxazole compound and method for producing the same
GB201012209D0 (en) * 2010-05-31 2010-09-08 Ge Healthcare Ltd In vivo imaging agent
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための１１−β−ＨＳＤ１のインヒビターとしてのアザスピロヘキサノン
KR20130137628A (ko) 2010-11-02 2013-12-17 베링거 인겔하임 인터내셔날 게엠베하 대사 장애를 치료하기 위한 약제학적 병용물
US9051333B2 (en) 2011-04-15 2015-06-09 Otsuka Pharmaceutical Co., Ltd. 6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides
JP2015006994A (ja) * 2011-10-28 2015-01-15 大正製薬株式会社 ジヒドロイミダゾオキサゾール誘導体
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
FR3000064A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
JP6532457B2 (ja) 2013-10-04 2019-06-19 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ ６−ニトロ−２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾール及びこれらの調製方法
CN103524492A (zh) * 2013-10-23 2014-01-22 中国药科大学 侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
TWI687409B (zh) 2014-08-28 2020-03-11 日商大塚製藥股份有限公司 稠合雜環化合物
JP6467042B2 (ja) * 2014-10-21 2019-02-06 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 抗マイコバクテリア剤としての置換１，２，３−トリアゾール−１−イル−メチル−２，３−ジヒドロ−２−メチル−６−ニトロイミダゾ［２，１−ｂ］オキサゾールとその調製方法
CN105732659B (zh) * 2014-12-12 2019-07-16 上海阳帆医药科技有限公司 硝基咪唑类化合物及其制备方法和在制药中的用途
JP6542900B2 (ja) * 2015-01-29 2019-07-10 メッドシャイン ディスカバリー インコーポレイテッド 抗肺結核症のニトロイミダゾール誘導体
US10252995B2 (en) 2015-03-27 2019-04-09 Otsuka Pharmaceutical Co., Ltd. Method for producing 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy)piperidine or salt thereof
CN106317072B (zh) * 2015-06-17 2020-03-17 盟科医药技术(上海)有限公司 用于分枝杆菌感染治疗的杂环化合物及其应用
US10851079B2 (en) 2016-02-26 2020-12-01 Otsuka Pharmaceutical Co., Ltd. Piperidine derivative
CN105859628B (zh) * 2016-04-19 2018-08-07 清远职业技术学院 一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
EP3489242A4 (en) * 2016-07-22 2020-06-24 Medshine Discovery Inc. NITROIMIDAZOLE CRYSTAL AND SALT, AND THEIR MANUFACTURING METHOD
ES2899365T3 (es) 2017-08-16 2022-03-11 Glaxosmithkline Ip Dev Ltd Compuestos novedosos
EA202092952A1 (ru) 2018-06-11 2021-03-22 Оцука Фармасьютикал Ко., Лтд. Содержащая деламанид композиция
CN109705022A (zh) * 2018-12-28 2019-05-03 上海彩迩文生化科技有限公司 一种芳香胺中间体的制备方法
CN112300192B (zh) * 2019-08-02 2023-08-11 南京长澳医药科技有限公司 硝基咪唑类化合物及其制备方法和用途
CN110483549B (zh) * 2019-08-30 2021-03-05 沈阳药科大学 一种硝基咪唑吡喃类抗结核药物的制备方法
CN110615800A (zh) * 2019-10-16 2019-12-27 李丽丽 硝基咪唑类化合物及其制备方法和用途
CN112156088B (zh) * 2020-10-30 2021-08-31 健民药业集团股份有限公司 一种化合物在制备结核分枝杆菌抑制剂中的用途
CN113603706A (zh) * 2021-08-04 2021-11-05 深圳市泰力生物医药有限公司 德拉马尼的晶型、含有该晶型的活性药物和药物组合物
CN119522100A (zh) 2022-07-29 2025-02-25 大塚制药株式会社 含有德拉马尼的固体分散体
CN115368252B (zh) * 2022-09-19 2024-01-12 西北农林科技大学 一种4-胺基酚类衍生物及应用
CN116640106B (zh) * 2023-05-11 2024-03-08 郑州大学 一种苯基哌嗪类化合物及其制备方法、应用
CN119059990B (zh) * 2024-11-01 2025-02-07 安徽昊帆生物有限公司 1-氨基甲酸叔丁酯哌嗪的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof

Also Published As

Publication number Publication date
BRPI0314344B8 (pt) 2021-05-25
EP1555267A4 (en) 2010-08-18
CA2497569C (en) 2011-05-24
HUS1400046I1 (hu) 2017-04-28
KR100723847B1 (ko) 2007-05-31
CY1113578T1 (el) 2016-06-22
CN101172981A (zh) 2008-05-07
HK1171018A1 (en) 2013-03-15
CN1705670A (zh) 2005-12-07
TW200420568A (en) 2004-10-16
CY2014041I1 (el) 2016-07-27
JP4186065B2 (ja) 2008-11-26
AR089950A2 (es) 2014-10-01
CN102532162B (zh) 2015-05-27
MY139244A (en) 2009-09-30
EP2570418A2 (en) 2013-03-20
RU2005114017A (ru) 2006-01-20
CA2497569A1 (en) 2004-04-22
BR0314344A (pt) 2005-07-12
PL409525A1 (pl) 2014-11-10
DK1555267T3 (da) 2013-02-11
RU2326121C3 (ru) 2021-09-17
LU92517I2 (fr) 2014-10-13
WO2004033463A1 (ja) 2004-04-22
PL217919B1 (pl) 2014-09-30
AR086485A2 (es) 2013-12-18
KR20050061473A (ko) 2005-06-22
TWI347946B (en) 2011-09-01
BRPI0314344B1 (pt) 2019-11-26
AR041198A1 (es) 2005-05-04
CN101255170A (zh) 2008-09-03
AU2003272979A1 (en) 2004-05-04
MXPA05003674A (es) 2005-06-08
HK1085463A1 (zh) 2006-08-25
AR091771A2 (es) 2015-02-25
US7262212B2 (en) 2007-08-28
EP1555267A1 (en) 2005-07-20
EP1555267B1 (en) 2013-01-16
RU2326121C2 (ru) 2008-06-10
ES2400179T3 (es) 2013-04-08
SI1555267T1 (sl) 2013-05-31
PL404913A1 (pl) 2013-09-30
EP2570418A3 (en) 2013-07-03
CY2014041I2 (el) 2016-07-27
CN100366624C (zh) 2008-02-06
JP2004149527A (ja) 2004-05-27
PL376157A1 (en) 2005-12-27
CN102532162A (zh) 2012-07-04
PT1555267E (pt) 2013-01-29
ZA200501033B (en) 2006-06-28
UA83200C2 (en) 2008-06-25
BE2014C053I2 (enrdf_load_stackoverflow) 2022-08-30
US20060094767A1 (en) 2006-05-04
AU2003272979B2 (en) 2009-07-23
FR14C0066I2 (fr) 2015-05-22

Similar Documents

Publication Publication Date Title
BE2019C547I2 (enrdf_load_stackoverflow)
BE2019C510I2 (enrdf_load_stackoverflow)
BE2018C021I2 (enrdf_load_stackoverflow)
BE2017C049I2 (enrdf_load_stackoverflow)
BE2017C005I2 (enrdf_load_stackoverflow)
BE2016C069I2 (enrdf_load_stackoverflow)
BE2016C040I2 (enrdf_load_stackoverflow)
BE2018C018I2 (enrdf_load_stackoverflow)
BE2016C013I2 (enrdf_load_stackoverflow)
BE2015C078I2 (enrdf_load_stackoverflow)
BE2016C002I2 (enrdf_load_stackoverflow)
BE2015C017I2 (enrdf_load_stackoverflow)
BE2014C053I2 (enrdf_load_stackoverflow)
BE2014C051I2 (enrdf_load_stackoverflow)
BE2014C041I2 (enrdf_load_stackoverflow)
BE2014C030I2 (enrdf_load_stackoverflow)
BE2014C016I2 (enrdf_load_stackoverflow)
BE2014C015I2 (enrdf_load_stackoverflow)
BE2013C063I2 (enrdf_load_stackoverflow)
BE2013C039I2 (enrdf_load_stackoverflow)
BE2011C038I2 (enrdf_load_stackoverflow)
JP2003153761A5 (enrdf_load_stackoverflow)
BE2015C068I2 (enrdf_load_stackoverflow)
BE2013C046I2 (enrdf_load_stackoverflow)
JP2003145638A5 (enrdf_load_stackoverflow)